| Analysis and interpretation of drug testing results from patients on chronic pain therapy: a clinical laboratory perspective. | |
| | |
MedLine Citation:
|
PMID: 19589103 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Recent guidelines recommend monitoring for opioid and drug use in patients with chronic pain to detect use of undisclosed or illicit substances, and to determine compliance with prescribed medications. We examined the technical and clinical impact of drug testing for patients on chronic pain therapy in our clinical laboratory. METHODS: Testing volumes were obtained for 4 years. Volumes from three recent months were also examined in detail to determine average turnaround time, assay performance (i.e., number of positive screening and confirmatory tests and testing discrepancies) and consistency of patient results with medication history. RESULTS: Our testing volume continues to grow significantly, especially in the primary care setting, with an average yearly increase of 34%. Approximately 70% of patients confirmed positive for an opioid. Other drugs were positive in <30% of patients. Twenty-nine percent of patients tested positive for a medication without a prescription. Overall, the compliance rate was 85% indicating that 15% of patients had negative test results despite being prescribed a chronic pain medication. CONCLUSIONS: Clinical laboratories should consider the impact of these guidelines and examine options to optimize testing such as limiting or modifying the test panel. |
| | |
Authors:
|
Stacy E F Melanson; Maria I Kredlow; Petr Jarolim |
Related Documents
:
|
14649463 - Temporal approach to hematological test usage in a major teaching hospital. 3446703 - Preoperative laboratory testing and podiatric surgery. 18930863 - Development and evaluation of the sinomenine transdermal patch. |
Publication Detail:
|
Type: Journal Article |
Journal Detail:
|
Title: Clinical chemistry and laboratory medicine : CCLM / FESCC Volume: 47 ISSN: 1434-6621 ISO Abbreviation: Clin. Chem. Lab. Med. Publication Date: 2009 |
Date Detail:
|
Created Date: 2009-07-31 Completed Date: 2009-10-27 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9806306 Medline TA: Clin Chem Lab Med Country: Germany |
Other Details:
|
Languages: eng Pagination: 971-6 Citation Subset: IM |
Affiliation:
|
Division of Clinical Laboratories, Department of Pathology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA. semelanson@partners.org |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Analgesics, Opioid
/
chemistry,
metabolism,
therapeutic use* Chronic Disease Drug Monitoring* Drug Prescriptions / statistics & numerical data Humans Pain / drug therapy* Patient Compliance / statistics & numerical data* Practice Guidelines as Topic Substance Abuse Detection Substance-Related Disorders / drug therapy* |
| Chemical | |
Reg. No./Substance:
|
0/Analgesics, Opioid |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Relationship of serum antioxidant micronutrients and sociodemographic factors to cervical neoplasia:...
Next Document: Unstimulated high sensitive thyroglobulin measurement predicts outcome of differentiated thyroid car...